Rodrigues, Manuel

Inserm · Institut Curie

1 paper on CoChatORCID 0000-0002-5443-0802

Most cited papers

Verified
Initial efficacy and safety results from ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC).
Banerjee, S. N., Ring, K. L., Van Nieuwenhuysen, E., Fabbro, M., Aghajanian, C., Oaknin, A., Colombo, N., Santin, A., Clamp, A. R., Moore, K. N., et al. (2023) · Journal of Clinical Oncology
Ovarian cancer diagnosis and treatmentOvarian function and disorders
Cited by 38

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free